KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Change in Cash (2016 - 2026)

Amgen has reported Change in Cash over the past 18 years, most recently at $2.9 billion for Q1 2026.

  • For Q1 2026, Change in Cash rose 191.97% year-over-year to $2.9 billion; the TTM value through Mar 2026 reached $3.2 billion, up 459.47%, while the annual FY2025 figure was -$2.8 billion, 376.38% down from the prior year.
  • Change in Cash for Q1 2026 was $2.9 billion at Amgen, up from -$316.0 million in the prior quarter.
  • Over five years, Change in Cash peaked at $23.9 billion in Q1 2023 and troughed at -$23.8 billion in Q4 2023.
  • A 5-year average of $238.2 million and a median of -$316.0 million in 2025 define the central range for Change in Cash.
  • On a YoY basis, Change in Cash climbed as much as 1737.99% in 2023 and fell as far as 1170.53% in 2023.
  • Year by year, Change in Cash stood at -$1.9 billion in 2022, then tumbled by 1170.53% to -$23.8 billion in 2023, then skyrocketed by 112.45% to $3.0 billion in 2024, then tumbled by 110.67% to -$316.0 million in 2025, then skyrocketed by 1020.57% to $2.9 billion in 2026.
  • Business Quant data shows Change in Cash for AMGN at $2.9 billion in Q1 2026, -$316.0 million in Q4 2025, and $1.4 billion in Q3 2025.